
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D2 Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
Lakshmi Vasudevan, Dasiel O. Borroto‐Escuela, Jelle Huysentruyt, et al.
Biomolecules (2019) Vol. 9, Iss. 8, pp. 368-368
Open Access | Times Cited: 16
Lakshmi Vasudevan, Dasiel O. Borroto‐Escuela, Jelle Huysentruyt, et al.
Biomolecules (2019) Vol. 9, Iss. 8, pp. 368-368
Open Access | Times Cited: 16
Showing 16 citing articles:
Receptor dimers and biased ligands: Novel strategies for targeting G protein-coupled receptors
Wenkai Liu, Dexiu Wang, Luoqi Wang, et al.
Pharmacology & Therapeutics (2025), pp. 108829-108829
Closed Access
Wenkai Liu, Dexiu Wang, Luoqi Wang, et al.
Pharmacology & Therapeutics (2025), pp. 108829-108829
Closed Access
Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
Elise Wouters, Adrián Ricarte Marín, James A. R. Dalton, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 30
Elise Wouters, Adrián Ricarte Marín, James A. R. Dalton, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1686-1686
Open Access | Times Cited: 30
Molecular, biochemical and behavioural evidence for a novel oxytocin receptor and serotonin 2C receptor heterocomplex
Barbara Chruścicka, Caitlin S.M. Cowan, Shauna E. Wallace Fitzsimons, et al.
Neuropharmacology (2020) Vol. 183, pp. 108394-108394
Open Access | Times Cited: 26
Barbara Chruścicka, Caitlin S.M. Cowan, Shauna E. Wallace Fitzsimons, et al.
Neuropharmacology (2020) Vol. 183, pp. 108394-108394
Open Access | Times Cited: 26
In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress
Marthe M. Vandeputte, Lakshmi Vasudevan, Christophe P. Stove
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108161-108161
Open Access | Times Cited: 14
Marthe M. Vandeputte, Lakshmi Vasudevan, Christophe P. Stove
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108161-108161
Open Access | Times Cited: 14
Exploring GPCR conformational dynamics using single-molecule fluorescence
Eugene Agyemang, Alyssa Gonneville, Sriram Tiruvadi Krishnan, et al.
Methods (2024) Vol. 226, pp. 35-48
Closed Access | Times Cited: 2
Eugene Agyemang, Alyssa Gonneville, Sriram Tiruvadi Krishnan, et al.
Methods (2024) Vol. 226, pp. 35-48
Closed Access | Times Cited: 2
Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders
Miguel Pérez de la Mora, Dasiel O. Borroto‐Escuela, Minerva Crespo‐Ramírez, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1826-1826
Open Access | Times Cited: 11
Miguel Pérez de la Mora, Dasiel O. Borroto‐Escuela, Minerva Crespo‐Ramírez, et al.
Cells (2022) Vol. 11, Iss. 11, pp. 1826-1826
Open Access | Times Cited: 11
Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders
René A. J. Crans, Elise Wouters, Marta Valle-León, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 16
René A. J. Crans, Elise Wouters, Marta Valle-León, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 16
Endogenous opiates and behavior: 2019
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
Richard J. Bodnar
Peptides (2021) Vol. 141, pp. 170547-170547
Closed Access | Times Cited: 15
Class A and C GPCR Dimers in Neurodegenerative Diseases
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Irina S. Moreira, Ana B. Caniceiro, Beatriz Bueschbell, et al.
Current Neuropharmacology (2022) Vol. 20, Iss. 11, pp. 2081-2141
Open Access | Times Cited: 10
Opioid-Modulated Receptor Localization and Erk1/2 Phosphorylation in Cells Coexpressing μ-Opioid and Nociceptin Receptors
Guan‐Yu Zhuo, Ming‐Chi Chen, Tzu‐Yu Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1048-1048
Open Access | Times Cited: 5
Guan‐Yu Zhuo, Ming‐Chi Chen, Tzu‐Yu Lin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1048-1048
Open Access | Times Cited: 5
Exploring functional consequences of GPCR oligomerization requires a different lens
Kyla Bourque, Jace Jones-Tabah, Dominic Devost, et al.
Progress in molecular biology and translational science (2019), pp. 181-211
Closed Access | Times Cited: 14
Kyla Bourque, Jace Jones-Tabah, Dominic Devost, et al.
Progress in molecular biology and translational science (2019), pp. 181-211
Closed Access | Times Cited: 14
Moxie begets MOXI: The journey to a novel hypothesis about Mu-opioid and OXytocin system Interactions
Khalin E. Nisbett
Comprehensive Psychoneuroendocrinology (2024) Vol. 19, pp. 100244-100244
Open Access | Times Cited: 1
Khalin E. Nisbett
Comprehensive Psychoneuroendocrinology (2024) Vol. 19, pp. 100244-100244
Open Access | Times Cited: 1
The Balance of MU-Opioid, Dopamine D2 and Adenosine A2A Heteroreceptor Complexes in the Ventral Striatal-Pallidal GABA Antireward Neurons May Have a Significant Role in Morphine and Cocaine Use Disorders
Dasiel O. Borroto‐Escuela, Karolina Wydra, Ramón Fores‐Pons, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Dasiel O. Borroto‐Escuela, Karolina Wydra, Ramón Fores‐Pons, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Multitarget Ligands that Comprise Opioid/Nonopioid Pharmacophores for Pain Management: Current State of the Science
Émile Breault, Michael Desgagné, Jolien De Neve, et al.
Pharmacological Research (2024), pp. 107408-107408
Open Access
Émile Breault, Michael Desgagné, Jolien De Neve, et al.
Pharmacological Research (2024), pp. 107408-107408
Open Access
Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials.
Mohammad Hadi Nematollahi, Mohammad Ali Ahmadianmoghadam, Mehrnaz Mehrabani, et al.
PubMed (2022) Vol. 14, Iss. 2, pp. 152-163
Closed Access
Mohammad Hadi Nematollahi, Mohammad Ali Ahmadianmoghadam, Mehrnaz Mehrabani, et al.
PubMed (2022) Vol. 14, Iss. 2, pp. 152-163
Closed Access
Could Agomelatine Play a Role to Treat Anhedonia in Heroin Dependence?
M. Preve
Addictive Disorders & Their Treatment (2021) Vol. 20, Iss. 3, pp. 211-212
Closed Access
M. Preve
Addictive Disorders & Their Treatment (2021) Vol. 20, Iss. 3, pp. 211-212
Closed Access